Food and Drug Administration (FDA) for any medical use
The most common side effects of GLP-1 receptor agonists are gastrointestinal: nausea (affecting 30-50% of patients during titration), vomiting, diarrhea, constipation, and abdominal discomfort
The intake-to-fulfillment sequence for a dual agonist Telehealth tirzepatide requests tend to move through the same gates: an intake form capturing weight, medical history and current medications
There's no strict maximum, but most physicians recommend periodic reassessment
Some patients experience rebound appetite and fatigue when intervals stretch beyond ten days, as GLP-1 receptor signaling drops sharply
They are potent medications that may potentially have interactions with the medicines you are on